Jeffrey Humphrey
Geen lopende functies
Vermogen: - $ op 29-02-2024
Profiel
Jeffrey S.
Humphrey served as President & Chief Medical Officer at Kyowa Kirin Pharmaceutical Development Ltd.
from 2013 to 2019.
He was also Senior Vice President-Drug Development at Kyowa Hakko Kirin Pharma, Inc. in 2012.
Humphrey served as Chief Development Officer at Kyowa Kirin Co., Ltd.
in 2019-2020 and as Chief Medical Officer at Constellation Pharmaceuticals, Inc. in 2020-2021.
He was an Independent Director at Cyteir Therapeutics, Inc. from 2021 to 2023 and Chief Medical Officer at Magenta Therapeutics, Inc. in 2021-2022.
Humphrey received his undergraduate degree from Harvard College and his doctorate from Case Western Reserve University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-10-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Eerdere bekende functies van Jeffrey Humphrey
| Bedrijven | Functie | Einde |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Director/Board Member | 29-11-2023 |
| MAGENTA THERAPEUTICS | Chief Tech/Sci/R&D Officer | 01-08-2022 |
| CONSTELLATION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 15-07-2021 |
| KYOWA KIRIN CO. LTD. | Corporate Officer/Principal | 01-06-2020 |
Kyowa Kirin Pharmaceutical Development Ltd.
 Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | President | 01-08-2019 |
Opleiding van Jeffrey Humphrey
| Harvard College | Undergraduate Degree |
| Case Western Reserve University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KYOWA KIRIN CO. LTD. | Health Technology |
| CYTEIR THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| Kyowa Hakko Kirin Pharma, Inc. | |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Kyowa Kirin Pharmaceutical Development Ltd.
Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Commercial Services |
